Clinical Trial Update: Initial Feasibility Study of the STENTiT Resorbable Fibrillated Scaffold (RFS). The RFS is Intended to Restore Lumen Patency and Blood Flow to Infrapopliteal Arteries. The RFS is a Fully Electrospun Tubular Device With a Fibrillated Microarchitecture and Designed for Transcatheter Delivery [NA]

View source ↗

Summary

Initial feasibility study of the STENTiT Resorbable Fibrillated Scaffold (RFS), a fully electrospun tubular device designed to restore lumen patency and blood f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• STENTiT Resorbable Fibrillated Scaffold (RFS)

Snippet

Sponsor: Stentit | Conditions: Critical Limb Ischemia (CLI) | NA | Status: RECRUITING